Sentinel lymph node assessment in breast cancer—an update on current recommendations

G Cserni, A Maguire, S Bianchi, A Ryska, A Kovács - Virchows Archiv, 2022 - Springer
Sentinel lymph node biopsy (SLNB) has become the preferred method of surgical
pathological nodal staging of early breast cancer by the end of the nineties. As the most …

The value of sentinel lymph-node biopsy after neoadjuvant therapy: an overview

JC Vázquez, A Piñero, FJ de Castro, A Lluch… - Clinical and …, 2022 - Springer
Purpose We conducted a systematic review to analyse the performance of the sentinel
lymph-node biopsy (SLNB) after the neoadjuvant chemotherapy, compared to axillary lymph …

[HTML][HTML] Pathology after neoadjuvant treatment–How to assess residual disease

G Viale, N Fusco - The Breast, 2022 - Elsevier
While systemic therapy for non-metastatic, invasive breast cancer is provided to minimize
the risk of recurrence, neoadjuvant therapy (NAT) is given prior to surgery to downstage the …

A rare case of invasive micropapillary carcinoma of the breast

GI Verras, F Mulita, L Tchabashvili, IM Grypari… - Menopause Review …, 2022 - termedia.pl
Invasive micropapillary carcinoma (IMPC) is a rare, distinct histological subtype of breast
carcinoma. While micropapillary histological architecture is found in up to 2–8% of all breast …

[HTML][HTML] Pathological examination of breast cancer samples before and after neoadjuvant therapy: recommendations from the Italian Group for the Study of Breast …

N Fusco, A Rizzo, L Costarelli, A Santinelli, B Cerbelli… - Pathologica, 2022 - ncbi.nlm.nih.gov
Neoadjuvant therapy (NAT) in breast cancer is administered to downstage the tumor, de-
escalate surgery, and provide prognostic information that can be used to tailor subsequent …

Current practice and surgical outcomes of neoadjuvant chemotherapy for early breast cancer: UK NeST study

H Fatayer, RL O'Connell, F Bannon… - British Journal of …, 2022 - academic.oup.com
Methods The NeST study protocol has been published previously 10. Briefly, this was a
prospective multicentre cohort study, including consecutive patients in participating units …

Study on intraoperative localization of sentinel lymph nodes using freehand SPECT in breast cancer patients

MI Argentou, E Iliopoulos, GI Verras, F Mulita… - Videosurgery and Other …, 2022 - termedia.pl
Study on intraoperative localization of sentinel lymph nodes using freehand SPECT in
breast cancer patients Page 1 641 Videosurgery Creative Commons licenses: This is an …

[PDF][PDF] 早期乳腺癌区域淋巴结局部处理

曹璐, 郑思悦, 陈佳艺 - 外科理论与实践, 2022 - qk.sjtu.edu.cn
早期乳腺癌区域淋巴结局部处理 Page 1 J Surg Concepts Pract 2022, Vol.27, No.5 !专家论坛!
早期乳腺癌区域淋巴结局部处理 曹潞, 郑思悦, 陈佳艺 (上海交通大学医学院附属瑞金医院放射 …

Tratamiento neoadyuvante en el cáncer de mama. El papel del patólogo

O Burgués, L Terrádez, E Buch, MT Martínez… - Revista de Senología y …, 2022 - Elsevier
El tratamiento neoadyuvante es una práctica estándar en las pacientes con cáncer de
mama, que permite realizar cirugías más conservadoras, aporta información pronóstica …

AGO-Empfehlungen zur operativen Therapie der Axilla nach neoadjuvanter Chemotherapie: Update 2021

M Friedrich, T Kühn, W Janni, V Müller… - Senologie-Zeitschrift …, 2022 - thieme-connect.com
Über viele Jahrzehnte war die komplette Ausräumung der axillären Lymphknoten im Sinne
einer Axilladissektion ein Standardverfahren in der Therapie des Mammakarzinom. Die …